Yves Poulin

12.4k total citations · 4 hit papers
169 papers, 7.1k citations indexed

About

Yves Poulin is a scholar working on Dermatology, Immunology and Epidemiology. According to data from OpenAlex, Yves Poulin has authored 169 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 109 papers in Dermatology, 98 papers in Immunology and 23 papers in Epidemiology. Recurrent topics in Yves Poulin's work include Psoriasis: Treatment and Pathogenesis (98 papers), Dermatology and Skin Diseases (82 papers) and Acne and Rosacea Treatments and Effects (24 papers). Yves Poulin is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (98 papers), Dermatology and Skin Diseases (82 papers) and Acne and Rosacea Treatments and Effects (24 papers). Yves Poulin collaborates with scholars based in Canada, United States and France. Yves Poulin's co-authors include Charles Lynde, Kim Papp, Marc Bourcier, Lyn Guenther, Robert Bissonnette, Kenneth B. Gordon, Ronald Vender, Richard G. Langley, Alice B. Gottlieb and Melinda Gooderham and has published in prestigious journals such as The Lancet, PEDIATRICS and Journal of Allergy and Clinical Immunology.

In The Last Decade

Yves Poulin

162 papers receiving 6.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials

2018 452 citations Kenneth B. Gordon, Bruce Strober et al. profile →
Topical tofacitinib for atopic dermatitis: a phase II a randomized trial

2016 320 citations Robert Bissonnette, Kim Papp et al. British Journal of Dermatology profile →
North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations

2019 224 citations Ali Alikhan, Christopher J. Sayed et al. Journal of the American Academy of Dermatology profile →
North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations

2019 222 citations Ali Alikhan, Christopher J. Sayed et al. Journal of the American Academy of Dermatology profile →

Peers

Countries citing papers authored by Yves Poulin

Since Specialization

Citations

This map shows the geographic impact of Yves Poulin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yves Poulin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yves Poulin more than expected).

Fields of papers citing papers by Yves Poulin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yves Poulin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yves Poulin. The network helps show where Yves Poulin may publish in the future.

Co-authorship network of co-authors of Yves Poulin

This figure shows the co-authorship network connecting the top 25 collaborators of Yves Poulin. A scholar is included among the top collaborators of Yves Poulin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yves Poulin. Yves Poulin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Practical and Relevant Guidelines for the Management of Psoriasis: An Inference-Based Methodology 2021 ·Dermatology and Therapy ·Kim Papp, Melinda Gooderham, Charles Lynde, Yves Poulin, Jennifer Beecker, Jan Dutz, Chih-ho Hong, Robert Gniadecki, Mark G. Kirchhof, Catherine Maari, Ronald Vender	7
2	Long‐term efficacy of certolizumab pegol for the treatment of plaque psoriasis: 3‐year results from two randomized phase III trials (CIMPASI‐1 and CIMPASI‐2) 2020 ·British Journal of Dermatology ·Kenneth B. Gordon, Richard B. Warren, Alice B. Gottlieb, Andrew Blauvelt, Diamant Thaçi, C. Leonardi, Yves Poulin, (unknown), (unknown), (unknown), Kristian Reich	14
3	Efficacy and safety of risankizumab vs. secukinumab in patients with moderate‐to‐severe plaque psoriasis (IMMerge): results from a phase III, randomized, open‐label, efficacy–assessor‐blinded clinical trial* 2020 ·British Journal of Dermatology ·Richard B. Warren, Andrew Blauvelt, Yves Poulin, (unknown), Matt Kelly, Tianshuang Wu, (unknown), C. Paul	135
4	Checklist for the Systemic Treatment of Psoriasis Using Biologics: A Delphi Study 2019 ·Journal of Cutaneous Medicine and Surgery ·Christine Fahim, (unknown), Marc Bourcier, Steven J. Glassman, Melinda Gooderham, Lyn Guenther, Wayne Gulliver, Charles Lynde, Yves Poulin, Melanie D. Pratt, Neil H. Shear, Ronald Vender, Scott R. Walsh, (unknown)	2
5	North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations breakdown → 2019 ·Journal of the American Academy of Dermatology ·Ali Alikhan, Christopher J. Sayed, Afsáneh Alavi, Raed Alhusayen, Alain Brassard, Craig N. Burkhart, Karen Crowell, Daniel B. Eisen, Alice B. Gottlieb, Iltefat Hamzavi, Paul G. Hazen, (unknown), Alexa B. Kimball, Joslyn S. Kirby, Michelle A. Lowes, Robert G. Micheletti, Angela P. Miller, Haley B. Naik, Dennis P. Orgill, Yves Poulin	222
6	Serious infections in patients with self-reported psoriatic arthritis from the Psoriasis Longitudinal Assessment and Registry (PSOLAR) treated with biologics 2019 ·BMC Rheumatology ·Christopher T. Ritchlin, Mona Ståhle, Yves Poulin, Jerry Bagel, Soumya D. Chakravarty, Shelly Kafka, Bhaskar Srivastava, Wayne Langholff, Alice B. Gottlieb	25
7	EFFICACY AND SAFETY OF RISANKIZUMAB: RESULTS FROM TWO DOUBLE-BLIND, PLACEBO- AND USTEKINUMAB-CONTROLLED, PHASE 3 TRIALS IN MODERATE-TO-SEVERE PLAQUE PSORIASIS 2018 ·Kenneth B. Gordon, Bruce Strober, Mark Lebwohl, Matthias Augustin, Andrew Blauvelt, Yves Poulin, Kim Papp, Howard Sofen, L. Puig, Peter Foley, Mamitaro Ohtsuki, Mary Flack, Ziqian Geng, Yihua Gu, Joaquin Valdes, Elizabeth H. Thompson, H. Bachelez	10
8	Efficacy of Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis in the North American Subgroup of Patients: Pooled Analysis of Four Phase 3 Studies 2017 ·Dermatology and Therapy ·David M. Pariser, Ellen Frankel, Joel Schlessinger, Yves Poulin, Ronald Vender, Richard G. Langley, Xiangyi Meng, Adriana Guana, Judit Nyirady	15
9	Topical tofacitinib for atopic dermatitis: a phase II a randomized trial breakdown → 2016 ·British Journal of Dermatology ·Robert Bissonnette, Kim Papp, Yves Poulin, Melinda Gooderham, Maitreyi Raman, Lotus Mallbris, C. Wang, Vivek S. Purohit, Carla Mamolo, Jocelyne Papacharalambous, W.C. Ports	320
10	Health-Related Quality of Life Worsens Disproportionately to Objective Signs of Psoriasis After Withdrawal of Adalimumab Therapy 2014 ·Dermatology and Therapy ·Yves Poulin, (unknown), Yihua Gu, Henrique D. Teixeira	12
11	The efficacy of adapalene-benzoyl peroxide combination increases with number of acne lesions 2011 ·Journal of the American Academy of Dermatology ·Steven R. Feldman, Jerry Tan, Yves Poulin, Thomas Dirschka, Nabil Kerrouche, Vasant K. Manna	31
12	Assessment of the long-term safety and effectiveness of etanercept for the treatment of psoriasis in an adult population 2010 ·Journal of the American Academy of Dermatology ·Kim Papp, Yves Poulin, Robert Bissonnette, Marc Bourcier, Darryl Toth, (unknown), Melanie Poulin-Costello, (unknown), Jerry Syrotuik	80
13	Long-term Safety and Efficacy of 50 mg of Etanercept Twice Weekly in Patients With Psoriasis 2007 ·Archives of Dermatology ·Stephen K. Tyring, Kenneth B. Gordon, Yves Poulin, Richard G. Langley, Alice B. Gottlieb, M. Dunn, Angelika Jahreis	268
14	XP-828L in the Treatment of Mild to Moderate Psoriasis: Randomized, Double-Blind, Placebo-Controlled Study 2006 ·Journal of Cutaneous Medicine and Surgery ·Yves Poulin, Robert Bissonnette, (unknown), (unknown), (unknown), Patrice E. Poubelle	12
15	Safety and Efficacy of a Milk-derived Extract in the Treatment of Plaque Psoriasis:An Open-label Study 2005 ·Journal of Cutaneous Medicine and Surgery ·Yves Poulin, Yves Pouliot, (unknown), (unknown), Sylvain Gauthier	14
16	Practical Approach to the Hormonal Treatment of Acne 2005 ·Journal of Cutaneous Medicine and Surgery ·Yves Poulin	8
17	Recommendations for incorporating biologicals into management of moderate to severe plaque psoriasis: individualized patient approaches 2005 ·Journal of Cutaneous Medicine and Surgery ·Richard G. Langley, Vincent Ho, Charles Lynde, Kim Papp, Yves Poulin, Neil H. Shear, J. Toole, Catherine Zip	19
18	A multicenter, double-blind, randomized comparison study of the efficacy and tolerability of once-daily tazarotene 0.1% gel and adapalene 0.1% gel for the treatment of facial acne vulgaris. 2002 ·PubMed ·Guy Webster, Lyn Guenther, Yves Poulin, Barry A. Solomon, Keith H. Loven, Jeff Lee	39
19	Randomized Placebo-controlled Trial of Metronidazole 1% Cream with Sunscreen SPF 15 in Treatment of Rosacea 2002 ·Journal of Cutaneous Medicine and Surgery ·Jerry Tan, C. Girard, Alfons Krol, (unknown), Kim Papp, Yves Poulin, (unknown), (unknown)	24
20	A comparison of tazarotene 0.1% gel once daily plus mometasone furoate 0.1% cream once daily versus calcipotriene 0.005% ointment twice daily in the treatment of plaque psoriasis 2000 ·Clinical Therapeutics ·Lyn Guenther, Yves Poulin, David M. Pariser	34

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact